AZIN1

AZIN1 Full Name

antizyme inhibitor 1

AZIN1 Introduction

AZIN1 (antizyme inhibitor 1) is a key regulator of polyamine metabolism that functions as a structural and functional homolog of ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. Unlike ODC, AZIN1 lacks decarboxylase activity but binds tightly to antizyme (AZ), a negative regulator of polyamine homeostasis. By sequestering antizyme, AZIN1 prevents antizyme from binding to ODC and targeting it for ubiquitin-independent proteasomal degradation. This interaction effectively increases ODC activity and cellular polyamine levels (putrescine, spermidine, and spermine), which are essential for cell growth, proliferation, differentiation, and apoptosis. The AZIN1 gene is ubiquitously expressed, with particularly high levels in the testis, liver, and rapidly proliferating tissues. Dysregulation of AZIN1, including its alternative splicing variant AZIN1-S (which lacks a small internal exon), has been implicated in various cancers, where it promotes tumor progression, metastasis, and chemoresistance.

Figure 1. Schematic structure of AZIN1.

Gene Structure and Regulatory Mechanism
The human AZIN1 gene is located on chromosome 8q22.3 and spans approximately 22 kb, containing 13 exons. Alternative splicing generates two major isoforms: the full-length AZIN1-L (long isoform) and the shorter AZIN1-S (short isoform), which lacks exon 7 (a 36-nucleotide in-frame deletion) and is the predominant isoform in human cancers. The protein consists of 448 amino acids (AZIN1-L) with a calculated molecular weight of approximately 50 kDa, sharing about 50% sequence identity with ODC. AZIN1 functions by mimicking ODC structure to bind antizyme with even higher affinity than ODC itself. When polyamine levels are high, antizyme is synthesized through a frameshifting mechanism and binds to ODC, marking it for degradation. AZIN1 competes with ODC for antizyme binding, and upon binding, the AZIN1-antizyme complex is stable but does not lead to AZIN1 degradation, thereby releasing ODC from antizyme-mediated inhibition. This creates a feedback loop where AZIN1 activity is induced by polyamines, further amplifying polyamine synthesis. AZIN1 also binds to and stabilizes other antizyme targets including cyclin D1 and aurora kinase A, extending its regulatory reach beyond polyamine metabolism.

Biological Functions in Normal Physiology and Disease
In normal physiology, AZIN1 plays essential roles in cell growth, tissue regeneration, and embryonic development by maintaining polyamine homeostasis. It is particularly important in the testis, where high polyamine levels are required for spermatogenesis, and in the liver, where it supports hepatocyte proliferation during regeneration. Genetic deletion of Azin1 in mice leads to embryonic lethality, underscoring its fundamental importance. In cancer, AZIN1 is frequently overexpressed and promotes tumor aggressiveness through multiple mechanisms. The cancer-associated AZIN1-S isoform has a longer half-life and higher antizyme-binding affinity than AZIN1-L, leading to constitutive ODC activation and sustained polyamine synthesis. Elevated AZIN1 expression has been documented in hepatocellular carcinoma, colorectal cancer, gastric cancer, breast cancer, prostate cancer, lung cancer, and glioblastoma. High AZIN1 levels correlate with advanced tumor stage, increased metastatic potential, poor patient survival, and resistance to chemotherapy including cisplatin and 5-fluorouracil. Mechanistically, AZIN1 promotes epithelial-mesenchymal transition (EMT) by stabilizing Snail and Twist transcription factors, enhances cancer stem cell properties, and activates pro-survival signaling pathways such as PI3K/Akt and MAPK/ERK.

Alternate Names for AZIN1

AZIN1; antizyme inhibitor 1; OAZI; OAZIN; ODC1L; AZI; ornithine decarboxylase antizyme inhibitor;